BNP Paribas Financial Markets’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-65,510
| Closed | -$3.04M | – | 3927 |
|
|
2019
Q2 | $3.04M | Buy |
65,510
+16,458
| +34% | +$762K | 0.01% | 860 |
|
|
2019
Q1 | $1.2M | Buy |
49,052
+32,117
| +190% | +$783K | ﹤0.01% | 1170 |
|
|
2018
Q4 | $241K | Sell |
16,935
-6,174
| -27% | -$88K | ﹤0.01% | 1416 |
|
|
2018
Q3 | $351K | Buy |
23,109
+2,352
| +11% | +$35.8K | ﹤0.01% | 1573 |
|
|
2018
Q2 | $348K | Sell |
20,757
-166,070
| -89% | -$2.79M | ﹤0.01% | 1585 |
|
|
2018
Q1 | $3.05M | Buy |
186,827
+145,976
| +357% | +$2.38M | 0.01% | 843 |
|
|
2017
Q4 | $523K | Buy |
40,851
+22,038
| +117% | +$282K | ﹤0.01% | 1842 |
|
|
2017
Q3 | $231K | Sell |
18,813
-1,013
| -5% | -$12.5K | ﹤0.01% | 2096 |
|
|
2017
Q2 | $166K | Buy |
19,826
+17,614
| +796% | +$147K | ﹤0.01% | 2188 |
|
|
2017
Q1 | $19.8K | Sell |
2,212
-797
| -26% | -$7.13K | ﹤0.01% | 2528 |
|
|
2016
Q4 | $26.4K | Sell |
3,009
-7,079
| -70% | -$62.2K | ﹤0.01% | 2588 |
|
|
2016
Q3 | $68.1K | Buy |
10,088
+4,466
| +79% | +$30.1K | ﹤0.01% | 2290 |
|
|
2016
Q2 | $20K | Buy |
+5,622
| New | +$20K | ﹤0.01% | 2587 |
|
|
2016
Q1 | – | Sell |
-32,432
| Closed | -$137K | – | 3322 |
|
|
2015
Q4 | $137K | Buy |
32,432
+3,267
| +11% | +$13.8K | ﹤0.01% | 2146 |
|
|
2015
Q3 | $133K | Buy |
29,165
+17,430
| +149% | +$79.5K | ﹤0.01% | 2206 |
|
|
2015
Q2 | $84.6K | Buy |
11,735
+8,423
| +254% | +$60.7K | ﹤0.01% | 2170 |
|
|
2015
Q1 | $24.4K | Buy |
+3,312
| New | +$24.4K | ﹤0.01% | 2280 |
|
|
2014
Q4 | – | Sell |
-7,462
| Closed | -$26.6K | – | 3137 |
|
|
2014
Q3 | $26.6K | Buy |
+7,462
| New | +$26.6K | ﹤0.01% | 2511 |
|
|
2014
Q1 | – | Sell |
-1,515
| Closed | -$7.59K | – | 3403 |
|
|
2013
Q4 | $7.59K | Sell |
1,515
-30,308
| -95% | -$152K | ﹤0.01% | 2353 |
|
|
2013
Q3 | $198K | Sell |
31,823
-10,031
| -24% | -$62.4K | ﹤0.01% | 1946 |
|
|
2013
Q2 | $190K | Buy |
+41,854
| New | +$190K | ﹤0.01% | 2030 |
|